FDA Inspection 1222897 — Michael Chung, M.D.

Michael Chung, M.D. — FEI 3026057413

The FDA completed an inspection of Michael Chung, M.D. on Nov 13, 2023 in Lynwood, CA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
Nov 13, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lynwood, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
749821 CFR 312.66Unanticipated problems
756021 CFR 312.60FD-1572, protocol compliance

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.